PGNY - Progyny, Inc.


18.02
-0.620   -3.441%

Share volume: 1,301,591
Last Updated: 04-21-2026
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$18.64
-0.62
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
34%
Profitability 40%
Dept financing 20%
Liquidity 35%
Performance 31%
Company vs Stock growth
vs
Performance
5 Days
3.96%
1 Month
3.50%
3 Months
-26.76%
6 Months
-3.97%
1 Year
-12.77%
2 Year
-43.62%
Key data
Stock price
$18.02
P/E Ratio 
37.83
DAY RANGE
$17.98 - $18.98
EPS 
$0.59
52 WEEK RANGE
$16.10 - $28.75
52 WEEK CHANGE
-$14.77
MARKET CAP 
2.214 B
YIELD 
N/A
SHARES OUTSTANDING 
81.902 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-05-2025
BETA 
1.31
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,436,882
AVERAGE 30 VOLUME 
$1,264,516
Company detail
CEO: Peter Anevski
Region: US
Website: progyny.com
Employees: 310
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Progyny, Inc. specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes personalized concierge-style member support services, and selective network of fertility specialists. The company also provides surrogacy and adoption reimbursement programs for employers.

Recent news